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Background and Significance 
 

 Kalman, Morissette and George (2005), Am. J. Addict., 14: 106-123  
• “Nicotine-dependent 
individuals with a 
comorbid mental illness 
made up 7.1% of the 
population yet 
consumed 34.2% of all 
cigarettes smoked in the 
United States” 
 
 
 
 
Grant, B.F. , Hasin, D.S., Chou, S.P., Stinson, F.S.& Dawson, D.A. (2004). Nicotine dependence and psychiatric 
disorders in the United States: Results from a national epidemiologic survey on alcohol and related conditions. Archives 
of General Psychiatry,61,1107-1115. 
Individuals living with mental illnesses have higher 
occurrences of tobacco caused mortality... 
•In an 13 year follow-up of 370 individuals living with schizophrenia, 
smoking related fatal diseases were more prominent than the general 
population. 
 
 
•Individuals living with severe mental illnesses (including schizophrenia, 
bipolar disorder, and depression) lose 25 years or more of life expectancy 
mostly related to cardiovascular disease 
 
 
•Individuals with severe mental illness are three times more likely to die 
from cardiovascular disease as compared to the general population 
Brown, Barraclough, & Inskip (2000) Causes of the excess mortality of schizophrenia. British Medical Journal. 
Newcomer et al (2007) Severe mental illness and risk for cardiovascular disease. JAMA. 
Osborn  et al. (2007). Relative Risk of Cardiovascular and Cancer Mortality in People With Severe Mental Illness From the 
United Kingdom's General Practice Research Database. Arch Gen Psychiatry 
Reasons for smoking among individuals living 
with mental illnesses 
 
 
• Psychosocial 
• Genetic • Biologic 
 (8,169 male twins) shared 
genetic disorders further 
predispose to major 
depression and nicotine 
dependence.  
 Kendler KS, Neale MC, MacLean CJ, et al. Smoking and Major Depression: A Causal Analysis. Archives of General Psychiatry 1993; 
50:36-43 
Lyons M, Hitsman B, Xian H, et al. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine & Tobacco 
Research 2008; 10:97 - 108 
(1,566 female twin pairs) average life 
time daily cigarette consumption was 
found to be associated with life time 
prevalence of major depression, 
suggesting that the relationship 
between smoking and major 
depression resulted solely from genes 
which predispose to both conditions. 
Genetic Reasons: Mental health and smoking 
• 63% of the association between post traumatic stress disorder 
and nicotine dependence co-morbidity was explained by 
shared genetic effects. 
Koenen KC, Hitsman B, Lyons MJ, et al. A Twin Registry Study of the Relationship Between Posttraumatic Stress Disorder and Nicotine 
Dependence in Men. Archives of General Psychiatry 2005; 62:1258-1265 
Genetic Reasons: Mental health and smoking 
Genetic Reasons: Mental health and smoking 
• Found a group of candidate genes and individual genes 
among individuals with schizophrenia which were significantly 
linked to smoking behaviors. 
Faraone et al. (2004). A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for 
smoking in Schizophrenia families 
Biologic reasons: Mental health and smoking 
Postma et al. 
Psychopharmacology (2006) 
184: 589–599 
 
nicotine reduces sensorimotor gating deficits in 
smokers with schizophrenia 
Barr, Culhane, Jubelt, et al. 
Neuropsychopharmacology 
2007; 33:480-490 
 
 
administration of transdermal patch nicotine 
improves attention and response inhibition in 
nonsmokers with schizophrenia 
Fowler, Volkow, Wang, et al. 
Proceedings of the National 
Academy of Sciences of the 
United States of America 
1996; 93:14065-14069 
 
 
brain levels of monoamine oxidase A (MAO-A) (an 
enzyme associated with depression) were reduced 
in smokers relative to nonsmokers; suggesting that 
people with affective disorders may smoke to 
reduce elevated MAO-A levels in the brain 
McCabe, Chudzik, Antony, 
et al. Journal of Anxiety 
Disorders 2004; 18:7-18 
Smokers with a primary diagnosis of anxiety 
disorder reported greater levels of general anxiety, 
distress, and depression as compared to 
nonsmokers. 
• History of tobacco use as a token economy--
cigarettes used as a ‘reward’ for appropriate 
behavior (i.e., smoking privileges) 
 
• Smoking among clients and staff to encourage 
‘socialization’  
 
Psychosocial reasons: Mental health and smoking 
Kawachi I, Berkman L. Social ties and mental health. Journal of Urban Health 2001; 78:458-467 
Lawn S. Cigarette smoking in psychiatric settings: occupational health, safety, welfare and legal concerns. Australian and New Zealand 
Journal of Psychiatry 2005; 39:886-891 
Keizer I, Eytan A. Variations in Smoking during Hospitalization in Psychiatric In-Patient Units and Smoking Prevalence in Patients and 
Health-Care Staff. International Journal of Social Psychiatry 2005; 51:317-328 
Morisano D, Bacher I, Audrain-McGovern J, et al. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive 
disorders. Canadian Journal Of Psychiatry. Revue Canadienne De Psychiatrie 2009; 54:356-367 
 
Arguments for Not Providing Tobacco Treatment…. 
“these patients don’t want to quit” 
 
 
• In a review of 9 studies of motivation to quit smoking among 
individuals with psychiatric disorders at least 50% are 
contemplating cessation  
(Siru, Hulse & Tait, 2009).  
“these patients are unable to quit” 
 
• Recent study found end-of-treatment smoking cessation rates of 
20% among individuals with psychiatric disorders accessing 
outpatient tobacco treatment program 
         (Selby et al, 2010) 
 
• Another recent study found end-of-treatment smoking cessation 
rates of 22.4% and smoking reduction of over 50% among 
participants in a smoking cessation program for individuals living 
with severe and persistent mental illness 
         (Masahura, Heah, and Okoli, 2012- under review) 
           
 
Smoking cessation medications  
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Smoking Cessation by length of stay in the program (n = 678)*  
Important considerations of smoking cessation for 
individuals living with mental illnesses 
• Concerns that smoking cessation will increase psychiatric symptoms 
or relapse among patients.  
o Among individuals with depression, smoking cessation related to increased 
depression symptomatology, which is one of the symptoms of the nicotine 
withdrawal syndrome 
o individuals with anxiety disorders and depression report more severe 
withdrawal symptoms 
o smoking is associated with improvements in prepulse inhibition and sensory 
gating which may be affected by smoking cessation 
Patten C, Martin J. Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues. Annals of Behavioral Medicine 1996; 18:190-200 
Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. American Journal of Psychiatry 1992; 
149:464-469 
Adams CE, Stevens KE. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Frontiers in Bioscience 2007; 12:4755-4772 
Kumari V, Postma P. Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience & Biobehavioral Reviews 2005; 29:1021-1034 
el-Guebaly N, Cathcart J, Currie S, et al. Public health and therapeutic aspects of smoking bans in mental health and addiction settings. Psychiatr Serv 2002; 53:1617-1622 
Ziedonis DMa, Williams JMb. Management of smoking in people with psychiatric disorders. Current Opinion in Psychiatry 2003; 16:305-315 
Costs associated with smoking cessation treatment 
• Even though less expensive than purchasing cigarettes, the cost of 
pharmacotherapy and counseling presents an important barrier to 
seeking treatment 
 
• Such cost barriers to accessing treatment and the potential cost-
effectiveness of treatment have prompted guidelines about 
reducing medication costs (reduced cost or free of charge), 
inclusion of medications as benefits on drug insurance plans, and 
setting up systems for reimbursement for tobacco cessation 
treatment for health care providers. 
Bansal MA, Cummings KM, Hyland A, et al. Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? 
Nicotine & Tobacco Research 2004; 6:303-310 
Reilly P, Murphy L, Alderton D. Challenging the smoking culture within a mental health service supportively. International Journal of Mental Health 
Nursing 2006; 15:272-278 
Fiore M, Jaén C, Baker T, et al. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update: A U.S. Public Health Service 
Report. American Journal of Preventive Medicine 2008; 35:158-176 
Raw M, McNeill A, West R. Smoking cessation: evidence based recommendations for the healthcare system. British Medical Journal 1999; 318:182-185 
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